English
العربية
cute Myeloid Leukemia (AML) Treatment in Turkey
What Is Acute Myeloid Leukemia?
Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow, the soft spongy tissue inside bones where blood cells are produced. The term “acute” refers to the rapid progression of the disease and the need for prompt medical treatment.
AML causes an accumulation of immature white blood cells within the bone marrow, which interferes with the production of healthy blood cells, including red blood cells, mature white blood cells, and platelets. This form of leukemia is characterized by its aggressive nature and significant impact on overall health if left untreated.
Acute Myeloid Leukemia is also known by several other names, including acute myelogenous leukemia, acute myeloblastic leukemia, acute granulocytic leukemia, and acute non-lymphocytic leukemia.
Symptoms of Acute Myeloid Leukemia
The symptoms of Acute Myeloid Leukemia (AML) often develop rapidly and may initially resemble those of influenza or other common illnesses, making early diagnosis challenging. Recognizing the signs and symptoms is essential for timely medical intervention.
Common symptoms of AML include:
- Fever: Elevated body temperature that may be accompanied by chills.
- Bone Pain: Localized or generalized pain affecting the bones.
- Fatigue and Weakness: Persistent tiredness and lack of energy.
- Shortness of Breath: Difficulty breathing, even during periods of rest.
- Pale Skin: Noticeable paleness resulting from anemia.
- Frequent Infections: Increased susceptibility to infections due to impaired immune function.
- Easy Bruising: Bruises appearing easily or without obvious cause.
- Unusual Bleeding: Including recurrent nosebleeds, bleeding gums, or prolonged bleeding from minor injuries.
Causes of Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) develops when bone marrow cells acquire genetic mutations within their DNA. DNA contains the instructions that regulate cell growth, division, and programmed cell death. In AML, these mutations cause cells to continue growing and dividing uncontrollably.
As a result, the body loses control over blood cell production, leading to the formation of abnormal immature cells known as myeloblasts. These abnormal cells fail to function properly and eventually crowd out healthy blood cells within the bone marrow.
Although the exact cause of the DNA mutations responsible for AML remains unclear, several risk factors have been identified that may increase the likelihood of developing the disease.
Risk Factors for Acute Myeloid Leukemia
Advanced Age
The risk of AML increases with age, and the disease is most commonly diagnosed in individuals over the age of 65.
Gender
AML is more frequently diagnosed in men than in women.
Previous Cancer Treatment
Individuals who have previously undergone chemotherapy or radiation therapy for other cancers may have an increased risk of developing AML.
Exposure to Radiation
Exposure to high levels of radiation, such as that experienced by survivors of nuclear accidents, has been associated with a higher risk of AML.
Exposure to Hazardous Chemicals
Long-term exposure to chemicals such as benzene is linked to an increased risk of Acute Myeloid Leukemia.
Smoking
Cigarette smoke contains carcinogenic substances, including benzene, which may contribute to the development of AML.
Other Blood Disorders
People with pre-existing blood disorders, such as myelodysplastic syndromes, myelofibrosis, or polycythemia vera, may be at increased risk.
Genetic Disorders
Certain inherited genetic conditions, including Down syndrome, have been associated with a higher likelihood of developing AML.
It is important to note that many individuals with risk factors never develop Acute Myeloid Leukemia, while some patients diagnosed with AML may have no known risk factors.
Diagnosis of Acute Myeloid Leukemia in Turkey
If you experience symptoms suggestive of Acute Myeloid Leukemia (AML), your physician may recommend a series of diagnostic tests to confirm the diagnosis and determine the specific characteristics of the disease.
Blood Tests
Blood tests often reveal abnormalities that may indicate AML, including elevated white blood cell counts, reduced red blood cell counts, and low platelet levels. In some cases, white blood cell counts may be unusually low. The presence of blast cells (immature blood cells) in the bloodstream is another important diagnostic indicator.
Bone Marrow Examination
A bone marrow biopsy is typically required to confirm the diagnosis of AML. During this procedure, a needle is used to obtain a sample of bone marrow, usually from the pelvic bone (hip bone), which is then analyzed in a specialized laboratory.
Lumbar Puncture
In selected cases, a sample of cerebrospinal fluid may be collected to determine whether leukemia cells have spread to the central nervous system. This procedure involves inserting a small needle into the lower spinal canal.
Laboratory Analysis of Leukemia Cells
Leukemia cells are analyzed in the laboratory to identify specific genetic mutations and chromosomal abnormalities. These findings help establish the diagnosis and guide treatment decisions.
If AML is suspected, patients are often referred to a hematologist or oncologist specializing in blood cancers for further evaluation and management.
Determining the AML Subtype
Following the diagnosis of Acute Myeloid Leukemia, additional testing may be required to determine the specific subtype of the disease and assess its biological characteristics.
Classification is based on how leukemia cells appear under the microscope, as well as specialized laboratory studies that evaluate genetic and molecular abnormalities. Identifying the AML subtype is essential for selecting the most appropriate treatment strategy.
Prognostic Assessment
Physicians use information regarding the AML subtype, along with several other factors, to evaluate prognosis and determine treatment options.
Unlike many solid tumors that are classified using traditional cancer staging systems, AML prognosis is assessed based on factors such as:
- The specific AML subtype
- Patient age
- Overall health condition
- Results of laboratory tests and diagnostic procedures
- White blood cell count at diagnosis
- Genetic and molecular characteristics of leukemia cells
Acute Myeloid Leukemia Treatment in Turkey
Acute Myeloid Leukemia (AML) requires a comprehensive treatment approach tailored to the individual patient. Treatment decisions depend on the AML subtype, patient age, general health status, and personal treatment preferences.
AML treatment typically consists of two major phases:
Induction Therapy
The first phase of treatment aims to eliminate leukemia cells from the blood and bone marrow. This is most commonly achieved through intensive chemotherapy. In some cases, additional therapies may be necessary to achieve complete remission. Treatment may continue even after an initial response is obtained.
Consolidation Therapy
Also referred to as post-remission therapy or maintenance therapy, consolidation treatment aims to destroy any remaining leukemia cells that may not be detectable through standard testing. This phase is essential for reducing the risk of relapse and maintaining long-term remission.
Treatment Options for Acute Myeloid Leukemia
Chemotherapy
Chemotherapy remains the cornerstone of AML treatment, particularly during induction therapy. It involves the use of powerful medications that target and destroy cancer cells throughout the body.
Because chemotherapy also affects healthy blood-forming cells, patients often require hospitalization for close monitoring and supportive care. If the initial treatment cycle does not achieve the desired response, additional chemotherapy cycles may be administered.
Targeted Therapy
Targeted therapy focuses on specific genetic mutations or molecular abnormalities within leukemia cells. These treatments are designed to attack cancer cells while minimizing damage to healthy tissues.
Targeted therapies may be used alone or in combination with chemotherapy, depending on the patient's disease characteristics.
Bone Marrow Transplantation (Stem Cell Transplantation)
Bone marrow transplantation, also known as stem cell transplantation, is an intensive treatment option used to restore healthy blood-forming stem cells within the bone marrow.
This procedure typically involves high-dose chemotherapy and, in some cases, radiation therapy to eliminate diseased bone marrow, followed by transplantation of healthy stem cells obtained from a compatible donor or previously collected from the patient.
Bone marrow transplantation may offer the possibility of long-term remission or cure in selected patients with AML.
Advanced AML Treatment in Turkey
Turkey is home to specialized hematology and oncology centers that provide advanced treatment options for Acute Myeloid Leukemia. These centers utilize modern diagnostic technologies, molecular testing, targeted therapies, and stem cell transplantation programs to deliver comprehensive care according to international treatment standards.
Patients seeking AML treatment in Turkey benefit from multidisciplinary medical teams, personalized treatment plans, and access to innovative therapeutic approaches.
Preparing for Acute Myeloid Leukemia Treatment in Turkey
Proper preparation for medical appointments is essential to ensure optimal care and effective communication with your healthcare team.
Before Your Appointment
Understand Any Pre-Appointment Requirements
Ask your healthcare provider whether there are any dietary restrictions or special preparations required before your visit or diagnostic testing.
Record Your Symptoms
Keep a detailed record of all symptoms you experience, including those that may seem unrelated to AML.
Gather Personal Information
Document any recent life changes, stressful events, or significant health developments that may be relevant to your medical evaluation.
Prepare a Medication List
Compile a complete list of all medications, vitamins, herbal products, and dietary supplements you are currently taking.
Consider Bringing a Companion
A family member or friend can help you remember important information discussed during your appointment.
Prepare Questions for Your Physician
Write down your questions in advance and prioritize the most important concerns to ensure they are addressed during your consultation.
Questions to Ask Your Doctor
You may wish to discuss the following questions with your healthcare provider:
- What is the most likely cause of my symptoms?
- Could there be alternative explanations for my condition?
- What diagnostic tests will I need?
- What treatment approach do you recommend?
- Are there alternatives to the proposed treatment?
- How can I manage my other medical conditions during treatment?
- Are there any restrictions I should follow?
- Is there a generic or alternative medication available?
- What signs or symptoms should prompt additional medical follow-up?
Questions Your Doctor May Ask
To better understand your condition and develop an appropriate treatment plan, your physician may ask questions such as:
- When did your symptoms first begin?
- Are your symptoms continuous or intermittent?
- How severe are your symptoms?
- Does anything improve your symptoms?
- Does anything appear to worsen your symptoms?
Providing accurate and detailed answers can help facilitate diagnosis and ensure the development of the most effective treatment strategy for your individual case.